Table I.
Age (years), No. (%) | |
All | 305 (100) |
6 to 11 | 164 (54) |
12 to 17 | 141 (46) |
Age at randomization, mean (SD), years | 11(3) |
Sex, No. (%) | |
Female | 118 (39) |
Male | 187 (61) |
Race, No. (%) | |
White | 102 (34) |
Black | 154 (50) |
Hispanic | 34 (11) |
Other | 15 (5) |
Asthma Characteristics | |
Age at asthma onset, mean (SD), years | 3 (3) |
Urgent care for asthma in past year, No. (%) | 224 (73) |
Oral corticosteroids for asthma in past year, No. (%) | 206 (67) |
Use of rescue inhaler 2 or more times/week*, No. (%) | 227 (74) |
Daily use of ICS/LABA in past 6 months, No. (%) | 177 (58) |
Daily use of leukotriene modifying agent, No. (%) | 167 (55) |
Self-Reported Atopic Conditions, No. (%) | |
Rhinitis | 181 (59) |
Eczema | 133 (43) |
Food allergies | 81 (26) |
Allergies worsen asthma | 245 (80) |
Asthma Questionnaires, mean (SD) | |
ACQ at randomization+ | 1.2 (0.8) |
cACT (ages 6-11) ++ | 19 (4) |
ACT (ages 12-17)# | 20 (4) |
ASUI## | 0.82 (0.15) |
Lung Function, mean (SD) | |
Pre-bronchodilator FEV1, % predicted | 91.9 (15.9) |
Post-bronchodilator FEV1, % predicted | 99.7 (14.8) |
Pre-bronchodilator FVC, % predicted | 100.8 (14.2) |
Post-bronchodilator FVC, % predicted | 103.0 (14.2) |
Change in FEV1 after bronchodilator | 9.7 (11.1) |
Change in FVC after bronchodilator | 2.8 (6.2) |
Use of rescue inhaler is based on self-report of average use in month prior to screening visit.
Range of ACQ score is 0 to 6 with lower scores indicating better asthma control.
Range of cACT score is 0 to 27 with higher scores indicating better asthma control.
Range of ACT score is 5 to 25 with higher scores indicating better asthma control.
Range of ASUI score is 0 to 1 with higher scores indicating better asthma control.